These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29880330)

  • 1. Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes.
    Ratnaseelan AM; Tsilioni I; Theoharides TC
    Clin Ther; 2018 Jun; 40(6):903-917. PubMed ID: 29880330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse human health effects associated with molds in the indoor environment.
    Hardin BD; Kelman BJ; Saxon A
    J Occup Environ Med; 2003 May; 45(5):470-8. PubMed ID: 12762072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mold and Mycotoxin Exposure and Brain Disorders.
    Ehsanifar M; Rajati R; Gholami A; Reiss JP
    J Integr Neurosci; 2023 Oct; 22(6):137. PubMed ID: 38176924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Large Case-series of Successful Treatment of Patients Exposed to Mold and Mycotoxin.
    Rea WJ
    Clin Ther; 2018 Jun; 40(6):889-893. PubMed ID: 29861191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health effects of mycotoxins in indoor air: a critical review.
    Robbins CA; Swenson LJ; Nealley ML; Gots RE; Kelman BJ
    Appl Occup Environ Hyg; 2000 Oct; 15(10):773-84. PubMed ID: 11036728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycotoxins as harmful indoor air contaminants.
    Jarvis BB; Miller JD
    Appl Microbiol Biotechnol; 2005 Jan; 66(4):367-72. PubMed ID: 15565335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspective.
    Kuhn DM; Ghannoum MA
    Clin Microbiol Rev; 2003 Jan; 16(1):144-72. PubMed ID: 12525430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stachybotrys chartarum (chartarum = atra = alternans) and other problems caused by allergenic fungi.
    Chapman JA
    Allergy Asthma Proc; 2003; 24(1):1-7. PubMed ID: 12635571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saliva secretory IgA antibodies against molds and mycotoxins in patients exposed to toxigenic fungi.
    Vojdani A; Kashanian A; Vojdani E; Campbell AW
    Immunopharmacol Immunotoxicol; 2003 Nov; 25(4):595-614. PubMed ID: 14686801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycotoxins and antifungal drug interactions: implications in the treatment of illnesses due to indoor chronic toxigenic mold exposures.
    Anyanwu EC; Campbell AW; Ehiri JE
    ScientificWorldJournal; 2004 Mar; 4():167-77. PubMed ID: 15105956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of indoor fungal diseases.
    McGinnis MR
    Med Mycol; 2004 Apr; 42(2):107-17. PubMed ID: 15124863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-allergenic impact of indoor mold exposure].
    Gautier C; Caillaud D; Charpin D
    Rev Mal Respir; 2018 Jun; 35(6):652-658. PubMed ID: 29983225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are indoor molds causing a new disease?
    Terr AI
    J Allergy Clin Immunol; 2004 Feb; 113(2):221-6. PubMed ID: 14722497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against molds and mycotoxins following exposure to toxigenic fungi in a water-damaged building.
    Vojdani A; Campbell AW; Kashanian A; Vojdani E
    Arch Environ Health; 2003 Jun; 58(6):324-36. PubMed ID: 14992307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stachybotrys chartarum, trichothecene mycotoxins, and damp building-related illness: new insights into a public health enigma.
    Pestka JJ; Yike I; Dearborn DG; Ward MD; Harkema JR
    Toxicol Sci; 2008 Jul; 104(1):4-26. PubMed ID: 18007011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Stachybotrys mycotoxins in building-related illness.
    Page EH; Trout DB
    AIHAJ; 2001; 62(5):644-8. PubMed ID: 11669391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molds, Mycotoxins, the Brain, the Gut and Misconceptions.
    Campbell AW; Weinstock LB
    Altern Ther Health Med; 2022 Mar; 28(3):8-12. PubMed ID: 35353713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurological significance of abnormal natural killer cell activity in chronic toxigenic mold exposures.
    Anyanwu E; Campbell AW; Jones J; Ehiri JE; Akpan AI
    ScientificWorldJournal; 2003 Nov; 3():1128-37. PubMed ID: 14625399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins.
    Hope J
    ScientificWorldJournal; 2013; 2013():767482. PubMed ID: 23710148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Health effects of indoor molds].
    Buzina W
    Wien Med Wochenschr; 2007; 157(19-20):462-5. PubMed ID: 18030548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.